PL3322480T3 - Bakterie Lactobacillus w leczeniu zaburzeń czynności serca - Google Patents
Bakterie Lactobacillus w leczeniu zaburzeń czynności sercaInfo
- Publication number
- PL3322480T3 PL3322480T3 PL16736860T PL16736860T PL3322480T3 PL 3322480 T3 PL3322480 T3 PL 3322480T3 PL 16736860 T PL16736860 T PL 16736860T PL 16736860 T PL16736860 T PL 16736860T PL 3322480 T3 PL3322480 T3 PL 3322480T3
- Authority
- PL
- Poland
- Prior art keywords
- treatment
- cardiac dysfunction
- lactobacillus bacteria
- lactobacillus
- bacteria
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/326—Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/181—Salivarius
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562193539P | 2015-07-16 | 2015-07-16 | |
| GBGB1514302.7A GB201514302D0 (en) | 2015-07-16 | 2015-08-12 | Lactobacilli for treating cardiac dysfunction |
| PCT/EP2016/066185 WO2017009188A1 (en) | 2015-07-16 | 2016-07-07 | Lactobacilli for treating cardiac dysfunction |
| EP16736860.4A EP3322480B1 (en) | 2015-07-16 | 2016-07-07 | Lactobacilli for treating cardiac dysfunction |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3322480T3 true PL3322480T3 (pl) | 2021-04-19 |
Family
ID=54200651
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16736860T PL3322480T3 (pl) | 2015-07-16 | 2016-07-07 | Bakterie Lactobacillus w leczeniu zaburzeń czynności serca |
Country Status (7)
| Country | Link |
|---|---|
| US (4) | US20180207210A1 (pl) |
| EP (1) | EP3322480B1 (pl) |
| DK (1) | DK3322480T3 (pl) |
| ES (1) | ES2834736T3 (pl) |
| GB (1) | GB201514302D0 (pl) |
| PL (1) | PL3322480T3 (pl) |
| WO (1) | WO2017009188A1 (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2021010160A (es) * | 2019-02-22 | 2021-09-14 | Evelo Biosciences Inc | Preparaciones de membrana bacteriana. |
| US20250136924A1 (en) * | 2023-10-26 | 2025-05-01 | Gene Guard Detox, Inc. | Food grade bacteria and methods for removing glyphosate and other harmful substances |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20030274A1 (es) * | 2001-07-26 | 2003-05-08 | Alimentary Health Ltd | Cepas de lactobacillus salivarius |
| EP1608383A1 (en) * | 2003-03-31 | 2005-12-28 | Alimentary Health Limited | A formulation comprising a bacterial strain |
| US20110189149A1 (en) * | 2008-06-20 | 2011-08-04 | Remy Burcelin | New Uses of Lactic Acid Bacteria and Bifidobacteria |
| EP2808024B1 (en) * | 2009-06-19 | 2019-04-24 | DuPont Nutrition Biosciences ApS | Bifidobacteria for treating congestive heart failure |
| CN103189504B (zh) * | 2010-06-18 | 2017-05-24 | 北卡罗莱纳州立大学 | 减少炎性反应的具有减少的脂磷壁酸的重组乳杆菌 |
| JP6286434B2 (ja) * | 2012-09-20 | 2018-02-28 | プロセラ インコーポレイテッド | 肥満および肥満関連疾患の治療のためのプロバイオティクス組成物および方法 |
-
2015
- 2015-08-12 GB GBGB1514302.7A patent/GB201514302D0/en not_active Ceased
-
2016
- 2016-07-07 DK DK16736860.4T patent/DK3322480T3/da active
- 2016-07-07 US US15/744,252 patent/US20180207210A1/en not_active Abandoned
- 2016-07-07 ES ES16736860T patent/ES2834736T3/es active Active
- 2016-07-07 PL PL16736860T patent/PL3322480T3/pl unknown
- 2016-07-07 WO PCT/EP2016/066185 patent/WO2017009188A1/en not_active Ceased
- 2016-07-07 EP EP16736860.4A patent/EP3322480B1/en active Active
-
2020
- 2020-06-30 US US16/916,425 patent/US20210346439A1/en not_active Abandoned
-
2023
- 2023-03-31 US US18/194,313 patent/US20240041953A1/en not_active Abandoned
-
2025
- 2025-02-03 US US19/044,070 patent/US20250262255A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20250262255A1 (en) | 2025-08-21 |
| DK3322480T3 (da) | 2021-01-04 |
| US20240041953A1 (en) | 2024-02-08 |
| WO2017009188A1 (en) | 2017-01-19 |
| EP3322480A1 (en) | 2018-05-23 |
| US20180207210A1 (en) | 2018-07-26 |
| GB201514302D0 (en) | 2015-09-23 |
| US20210346439A1 (en) | 2021-11-11 |
| ES2834736T3 (es) | 2021-06-18 |
| EP3322480B1 (en) | 2020-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL283086A (en) | Use of cannabidiol in the treatment of tuberous sclerosis complex | |
| IL279752B (en) | Polycyclic compounds and use thereof in the treatment of immune disorders | |
| IL257105A (en) | Modified cells and methods of therapy | |
| IL253803B (en) | A preparation for the treatment of hypothyroidism | |
| IL260684B (en) | Treatment for modulating gut microbiota | |
| PL3157512T3 (pl) | Zastosowanie kannabidioli w leczeniu padaczki | |
| PL3265053T3 (pl) | Sposoby leczenia skóry | |
| PL3943093T3 (pl) | Zastosowanie pasteryzowanej akkermansia do leczenia nowotworu złośliwego | |
| GB2554629B8 (en) | Prevention and treatment of microbial infections | |
| HUE061761T2 (hu) | Tetrahidropiranil-amino-pirrolopirimidinon felhasználásra BTK-által közvetített zavarok kezelésében | |
| PL3503890T3 (pl) | Stosowanie pridopidyny w leczeniu dystonii | |
| EP3334429C0 (en) | HYPERPHENYLALANINEMIA AND TREATMENTS THEREFOR | |
| IL258259A (en) | Adjunctive therapy with 25-hydroxyvitamin d and articles therefor | |
| PL3773715T3 (pl) | Mirikizumab w leczeniu wrzodziejącego zapalenia jelita grubego | |
| IL268210A (en) | Use of gaboxadol in the treatment of tinnitus | |
| SG11201607081RA (en) | Massage chair and method of driving the same | |
| IL242971B (en) | Ventricular far field reduction | |
| PL3236960T3 (pl) | Fluralaner do zastosowania w leczeniu demodekozy | |
| EP3728562A4 (en) | HEART MICROTISSUE AND ASSOCIATED USES | |
| PT3285787T (pt) | Tratamento de infeções bacterianas em aquicultura | |
| GB201404372D0 (en) | Assay and treatment | |
| PL3373922T3 (pl) | Kompozycje i sposoby do stosowania do leczenia homocystynurii | |
| LT3405197T (lt) | Delgocitinibo panaudojimas lėtinės rankų egzemos gydymui | |
| GB201614415D0 (en) | Enzymes for the treatment of human enterometabolic dysfunction | |
| IL251840A0 (en) | Use of femiroplast in the treatment of severe asthma |